Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

PURPOSE: Treatment efficacy and toxicity are difficult to predict in lymphoma patients. In this study, the utility of circulating biomarkers in predicting and/or monitoring treatment efficacy/toxicity were investigated. PATIENTS AND METHODS: Circulating biomarkers of cell death (nucleosomal DNA (nDN...

Descripción completa

Detalles Bibliográficos
Autores principales: Greystoke, A, O'Connor, J P B, Linton, K, Taylor, M B, Cummings, J, Ward, T, Maders, F, Hughes, A, Ranson, M, Illidge, T M, Radford, J, Dive, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049589/
https://www.ncbi.nlm.nih.gov/pubmed/21245866
http://dx.doi.org/10.1038/sj.bjc.6606082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049589/
https://www.ncbi.nlm.nih.gov/pubmed/21245866
http://dx.doi.org/10.1038/sj.bjc.6606082

Ejemplares similares